AstraZeneca CFO Sarin acquired company shares
AstraZeneca PLC's Chief Financial Officer, Aradhana Sarin, acquired 73 company shares on September 14, 2026, following the vesting of dividend equivalent awards related to her 2021 Performance Share Plan.
AstraZeneca PLC announced that its Chief Financial Officer, Dr Aradhana Sarin, acquired 73 ordinary shares of the company on September 14, 2026. The acquisition followed the vesting of certain dividend equivalent awards accrued in relation to her 2021 AstraZeneca Performance Share Plan (AZPSP) award.
The underlying 2021 AZPSP award vested to Dr Sarin on August 17, 2026, and was announced on August 18, 2026. Due to administrative processing timelines, the dividend equivalent awards vested and the subsequent share acquisition occurred with a delay.
The transaction involved a person discharging managerial responsibilities within the company. The shares acquired are part of Dr Sarin's overall compensation structure, which includes long-term incentives.
This disclosure is part of standard regulatory reporting for public companies regarding changes in shareholdings by senior management. AstraZeneca's stock performance in 2026 has been subject to broader market conditions within the pharmaceutical sector.